Creutzfeldt‐Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Transfusion

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/trf.14145PMID 28444687PMCID PMC6553617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.

  2014cited by this paper
• Survival of blood transfusion recipients identified by a look-back investigation.

  2014cited by this paper
• Detection of Infectivity in Blood of Persons with Variant and Sporadic Creutzfeldt-Jakob Disease

  2014cited by this paper
• Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease

  2012cited by this paper
• Sporadic Creutzfeldt‐Jakob disease and risk of blood transfusion in the United Kingdom

  2011cited by this paper
• Transmission of sporadic Creutzfeldt‐Jakob disease by blood transfusion: risk factor or possible biases

  2011cited by this paper
• Research Letters

  2010cited by this paper
• Lack of evidence of transfusion transmission of Creutzfeldt‐Jakob disease in a US surveillance study

  2009cited by this paper
• Transfusion transmission of human prion diseases.

  2008cited by this paper
• Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

  2006cited by this paper
• Three reported cases of variant Creutzfeldt–Jakob disease transmission following transfusion of labile blood components

  2006cited by this paper
• Creutzfeldt–Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study

  2006cited by this paper
• Bring back compassion

  2006cited by this paper
• Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

  2004cited by this paper
• The United Kingdom

  2001cited by this paper
• Creutzfeldt-Jakob disease and blood transfusion.

  1991cited by this paper

• The infectious potential of protein misfolding: insights from cross-over studies of prion diseases and common neurodegenerative disorders.

  2025cites this paper
• Review of Established and Emerging Infectious Diseases in Transfusion Medicine.

  2025cites this paper
• Prescribing Considerations for Intravenous Albumin: Update for the Clinical Nurse Specialist.

  2025cites this paper
• Prions

  2024cites this paper
• Pathological spectrum of sporadic Creutzfeldt-Jakob disease.

  2024cites this paper
• Prion agents (1st section)

  2024cites this paper
• Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks.

  2023cites this paper
• How do we forecast tomorrow's transfusion: Infectious safety?

  2022cites this paper
• Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis

  2022cites this paper
• The importance of ongoing international surveillance for Creutzfeldt–Jakob disease

  2021cites this paper
• Blood Product (Donor) Noninfectious and Infectious Testing and Modification.

  2021cites this paper
• Modern Blood Banking

  2021cites this paper
• Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases

  2020cites this paper
• No evidence of transfusion transmitted sporadic Creutzfeldt‐Jakob disease: results from a bi‐national cohort study

  2020cites this paper
• Is sporadic Creutzfeldt‐Jakob disease transfusion‐transmissible?

  2020cites this paper
• Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993–2018

  2020cites this paper
• Prion disease and recommended procedures for flexible endoscope reprocessing - review of policies worldwide and proposal for a simplified approach.

  2019cites this paper
• Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee

  2019cites this paper
• Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion.

  2019cites this paper
• Prevention of transfusion-transmitted infections.

  2019cites this paper
• Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk

  2019cites this paper
• Prion Diseases.

  2018cites this paper
• Creutzfeldt‐Jakob disease and blood transfusion safety

  2018cites this paper
• Haematology patients and the risk of transfusion transmitted infection

  2018cites this paper
• Transfusion-associated hazards: A revisit of their presentation.

  2018cites this paper
• Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee

  2018cites this paper
• Prion Disease: A Review of Novel Transmission Methods and Efforts at Discovering Preventive and Therapeutic Modalities

  2018influential citation
• Human transmissible spongiform encephalopathies: historic view.

  2018cites this paper
• Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead

  2018cites this paper
• Creutzfeldt‐Jakob disease and blood transfusion: safe or not safe?

  2017influential citation
• Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates

  2017cites this paper
• Nonhuman Primates in Research on Transmissible Spongiform Encephalopathies

  2017cites this paper
• CHMP position statement on Creutzfeldt-Jakob disease 4 and plasma-derived and urine-derived medicinal products

  year unknowncites this paper
• CHMP Reflection paper on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products

  year unknowncites this paper